K24-27849-80058
4 vaccinations
2 coded responses
37 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 372 / TN
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-03-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Muscle or body aches, NauseaAdult check-in
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-03-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Nausea, DiarrheaAdult check-in
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-06-10
- 2021-09-06
-
2021-10-24
Dose 2 — Moderna
- 2021-10-31
- 2021-11-07
- 2021-11-14
- 2021-11-21
- 2021-11-28
- 2021-12-05
- 2022-01-23
- 2022-04-24
-
2022-04-26
Dose 3 — Moderna
- 2022-05-01
- 2022-05-02
- 2022-05-03
- 2022-05-10
-
2022-05-17
Survey response — day 21, dose 3MedDRA: Chills, Oropharyngeal pain, Pain, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Runny nose, aches, chills, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-05-17
Report sent to call center — day 21, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-18
- 2022-05-24
-
2022-05-31
Survey response — day 35, dose 3MedDRA: Asthenia, Cough, Increased need for sleep, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Lingering cough and runny nose/sneezing, low energy for exercise, needing more sleep than usualMedDRA releases: 2024-11 · check-in free text available
- 2022-06-07
- 2022-07-26
-
2022-09-21
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-20
- 2022-10-26
- 2022-11-02
- 2022-12-21
- 2023-03-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-24 | Moderna | No |
| 3 | 2022-04-26 | Moderna | No |
| 4 | 2022-09-21 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 11 — day 21, dose 3
Symptoms: Runny nose, aches, chills, sore throat
Release 11 — day 35, dose 3
Symptoms: Lingering cough and runny nose/sneezing, low energy for exercise, needing more sleep than usual
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Increased need for sleep | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release